Latest News
MVM invests in eXmoor Pharma
MVM led a financing of eXmoor Pharma, an expert cell and gene therapy services company.
Hologic announces acquisition of Biotheranostics
Hologic, Inc., a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers.
MVM Winter 2020 Newsletter
Recent updates regarding MVM team, new investments, and portfolio.
MVM invests in GT Medical
MVM led the Series B financing of GT Medical Technologies, a company dedicated to improving the lives of patients with brain tumors.
Valneva announces major COVID-19 vaccine partnership with UK government
UK government invests in Valneva's manufacturing facility and secures supply of 60 million doses of Valneva's inactivated COVID-19 vaccine VLA2001, with option for another 130 million doses.
MVM Summer 2020 Newsletter
Recent updates regarding MVM team, new investments, and portfolio.